Pine Pharmaceuticals is pleased to announce that Annet Benny has been named Director of Quality. Annet joins Pine with 12+ years of pharmaceutical industry experience and a track record of leading successful FDA and Health Canada inspections, most recently in a leadership role at another 503B outsourcing facility.
Annet is a pharmacy graduate with a background spanning quality management systems, deviation and CAPA management, change control, aseptic processing and sterility assurance, and data integrity and audit readiness. Her career has included site quality leadership roles across the pharmaceutical industry, building deep experience across cGMP, GLP, ICH, and ISO standards.
Annet steps into the role following an extensive transition period with Gayle Gleason, who retired in August after more than three years of service to Pine. We are grateful for Gayle’s contributions and leadership, and for the smooth handoff she helped make possible.
“I’m honored to join Pine and to build on the strong quality foundation Gayle helped establish. Data integrity, compliance, and continuous improvement have been at the center of my career, and I’m looking forward to working alongside this team to keep strengthening our quality systems as Pine continues to grow.”
We are excited to welcome Annet to the team and confident she will continue to strengthen Pine’s quality systems and regulatory readiness as we grow.
©2026 Pine Pharmaceuticals. All rights reserved.